Cadila Healthcare (Zydus Cadila) has received final approval from USFDA to market Topiramate tablets in different strengths of 25 mg., 50 mg., 100 mg., and 200 mg.
The drug falls in the anti-epileptic segment. The sales of Topiramate tablets as per NDC Health was estimated at USD 2.6 billion in 2008.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment